Media Pack
News

Current Edition

Volume 16 Issue 1
 
Regional News

Amid corporate restructuring, Novartis plots 680 layoffs in development group

Even as Novartis rolls ahead with a global restructuring campaign targeting thousands of job cuts, the Swiss drug giant has blueprinted several hundred layoffs in it...
11 April 2024 Regional News
Continue Reading →
Regional News

Medicare price negotiations carry on as HHS responds to Big Pharma’s IRA counteroffers

Medicare drug price negotiations under the Inflation Reduction Act are steadily progressing after drugmakers recently submitted their counteroffers to the government...
4 April 2024 Regional News
Continue Reading →
Regional News

Vanda secures FDA approval for Fanapt to treat bipolar I, 15 years after schizophrenia nod

Fifteen years after gaining its first FDA approval for Fanapt (iloperidone) to treat schizophrenia, Vanda Pharmaceuticals has scored again with the same antipsychoti...
4 April 2024 Regional News
Continue Reading →
Regional News

Thermo Fisher plots layoffs at California plasmid manufacturing site as demand swings

Demand fluctuations have spurred Thermo Fisher Scientific to downsize at the plasmid DNA manufacturing facility the company opened a little less than three years ago...
4 April 2024 Regional News
Continue Reading →
Regional News

J&J doubles down on health equity with 100+ partnerships and renewed local health initiatives

As April’s National Minority Health Month begins, Johnson & Johnson is picking up the pace in its “race to health equity.” The company announced Wednesday tha...
4 April 2024 Regional News
Continue Reading →
Regional News

ALMAC SCIENCES AWARDED LIFE SCIENCES INNOVATIVE MANUFACTURING FUND GRANT

Grant awarded to support the expansion of Almac’s small molecule API manufacturing plant Almac Sciences, a member of the Almac Group, has been awarde...
14 March 2024 Regional News
Continue Reading →
Regional News

Mirum scores second FDA nod for rare liver disease drug Livmarli, this one to treat PFIC

With Livmarli sales reaching $142 million during its second full year on the market, Mirum Pharmaceuticals’ rare liver disease treatment is off to a solid start in f...
14 March 2024 Regional News
Continue Reading →
Regional News

Coherus again axes staff, with 30% of roles on chopping block amid ‘sharpened focus’ on cancer drugs

About a year after launching a prior round of layoffs, Coherus BioSciences is again reducing its head count, this time by 30%. Coherus unveiled the latest job cut...
14 March 2024 Regional News
Continue Reading →
Regional News

Skincare products maker Galderma gears up for long-awaited $2.6B IPO

After a few holdups, Swiss skincare company Galderma is finally going public in a highly anticipated market debut that could make for one of Europe’s largest listing...
14 March 2024 Regional News
Continue Reading →
Regional News

Biotech trade group pledges support for BIOSECURE Act, plans to boot member WuXi AppTec

As CDMO giants Wuxi AppTec and WuXi Biologics come under mounting scrutiny for their alleged ties to Chinese government officials, they are losing a key ally in Wash...
14 March 2024 Regional News
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte